Antihyperglycaemic and antihyperlipidemic effect of gymnema sylvestre in protracted diabetes mellitus in wistar rats

Bhagyajyothi M. Bhat, C. V. Raghuveer, Vivian D’souza, Poornima A. Manjrekar

Research output: Contribution to journalArticle

Abstract

Introduction: Dysregulation in glucose and lipid metabolism have been observed in the early phases of Diabetes Mellitus (DM) which may further lead to insulin resistance and beta-cell failure. Effective control of these metabolic alterations may delay the clinical onset of diabetes. A proven herbal medication with antihyperglycaemic activity used in the treatment of Diabetes is Gymnema sylvestre (GSE). An extensive study regarding its benefits in treating long standing diabetes and associated dyslipidemia is obligatory. Aim: To study the effects and optimal dosage of a standardized hydroalcoholic leaf extract of GSE on glycaemic and lipid parameters in diabetic rats. Materials and Methods: Wistar rats of either sex were divided into five groups with eight rats in each group. Single dose of Streptozotocin (STZ) (50mg/Kg body weight) was used to induce DM. The diabetic rats were treated with two oral doses of the GSE at 1g and 2.5 g/kg body wt/day and Glibenclamide (Glb) (500 µg/kg body weight) for a period of 16 weeks. Fasting Blood Glucose (FBG) was checked at day-1 and at the end of 16 weeks. Plasma glycated Haemoglobin (HbA1c), serum insulin, serum Triacylglycerol (TG), Total Cholesterol (TC) and High Density Lipoprotein fraction of Cholesterol (HDL-C) were measured at the end of the study. Statistical analysis was done using the software SPSS-20. Results: Significant decrease in FBG in a dose dependent manner was observed along with increase in serum insulin and decrease in HbA1c levels. Treatment with GSE decreased TG levels significantly and was comparable with Glb. Improvement in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was not significant, but that of Triglyceride Glucose Index (TGI) was significant. GSE at the dose of 2.5g/kg body weight showed a positive correlation between HOMA-IR and TGI (p=0.01) and was comparable with the results of Glb. Conclusion: GSE had a sustained and dose dependent effect in improving glycaemic parameters and TG in diabetic rats of protracted duration. Insulin resistance did not vary significantly from the diabetic control rats.

Original languageEnglish
JournalJournal of Clinical and Diagnostic Research
Volume12
Issue number11
DOIs
Publication statusPublished - 01-11-2018

Fingerprint

Gymnema sylvestre
Hypolipidemic Agents
Medical problems
Hypoglycemic Agents
Wistar Rats
Rats
Diabetes Mellitus
Insulin
Triglycerides
Insulin Resistance
Glyburide
Body Weight
Glucose
Blood Glucose
Fasting
Serum
Rat control
Glycosylated Hemoglobin A
Streptozocin
Dyslipidemias

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{290ef000da7542a1b05b47cdf6380605,
title = "Antihyperglycaemic and antihyperlipidemic effect of gymnema sylvestre in protracted diabetes mellitus in wistar rats",
abstract = "Introduction: Dysregulation in glucose and lipid metabolism have been observed in the early phases of Diabetes Mellitus (DM) which may further lead to insulin resistance and beta-cell failure. Effective control of these metabolic alterations may delay the clinical onset of diabetes. A proven herbal medication with antihyperglycaemic activity used in the treatment of Diabetes is Gymnema sylvestre (GSE). An extensive study regarding its benefits in treating long standing diabetes and associated dyslipidemia is obligatory. Aim: To study the effects and optimal dosage of a standardized hydroalcoholic leaf extract of GSE on glycaemic and lipid parameters in diabetic rats. Materials and Methods: Wistar rats of either sex were divided into five groups with eight rats in each group. Single dose of Streptozotocin (STZ) (50mg/Kg body weight) was used to induce DM. The diabetic rats were treated with two oral doses of the GSE at 1g and 2.5 g/kg body wt/day and Glibenclamide (Glb) (500 µg/kg body weight) for a period of 16 weeks. Fasting Blood Glucose (FBG) was checked at day-1 and at the end of 16 weeks. Plasma glycated Haemoglobin (HbA1c), serum insulin, serum Triacylglycerol (TG), Total Cholesterol (TC) and High Density Lipoprotein fraction of Cholesterol (HDL-C) were measured at the end of the study. Statistical analysis was done using the software SPSS-20. Results: Significant decrease in FBG in a dose dependent manner was observed along with increase in serum insulin and decrease in HbA1c levels. Treatment with GSE decreased TG levels significantly and was comparable with Glb. Improvement in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was not significant, but that of Triglyceride Glucose Index (TGI) was significant. GSE at the dose of 2.5g/kg body weight showed a positive correlation between HOMA-IR and TGI (p=0.01) and was comparable with the results of Glb. Conclusion: GSE had a sustained and dose dependent effect in improving glycaemic parameters and TG in diabetic rats of protracted duration. Insulin resistance did not vary significantly from the diabetic control rats.",
author = "Bhat, {Bhagyajyothi M.} and Raghuveer, {C. V.} and Vivian D’souza and Manjrekar, {Poornima A.}",
year = "2018",
month = "11",
day = "1",
doi = "10.7860/JCDR/2018/38378.12291",
language = "English",
volume = "12",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "11",

}

Antihyperglycaemic and antihyperlipidemic effect of gymnema sylvestre in protracted diabetes mellitus in wistar rats. / Bhat, Bhagyajyothi M.; Raghuveer, C. V.; D’souza, Vivian; Manjrekar, Poornima A.

In: Journal of Clinical and Diagnostic Research, Vol. 12, No. 11, 01.11.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antihyperglycaemic and antihyperlipidemic effect of gymnema sylvestre in protracted diabetes mellitus in wistar rats

AU - Bhat, Bhagyajyothi M.

AU - Raghuveer, C. V.

AU - D’souza, Vivian

AU - Manjrekar, Poornima A.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Introduction: Dysregulation in glucose and lipid metabolism have been observed in the early phases of Diabetes Mellitus (DM) which may further lead to insulin resistance and beta-cell failure. Effective control of these metabolic alterations may delay the clinical onset of diabetes. A proven herbal medication with antihyperglycaemic activity used in the treatment of Diabetes is Gymnema sylvestre (GSE). An extensive study regarding its benefits in treating long standing diabetes and associated dyslipidemia is obligatory. Aim: To study the effects and optimal dosage of a standardized hydroalcoholic leaf extract of GSE on glycaemic and lipid parameters in diabetic rats. Materials and Methods: Wistar rats of either sex were divided into five groups with eight rats in each group. Single dose of Streptozotocin (STZ) (50mg/Kg body weight) was used to induce DM. The diabetic rats were treated with two oral doses of the GSE at 1g and 2.5 g/kg body wt/day and Glibenclamide (Glb) (500 µg/kg body weight) for a period of 16 weeks. Fasting Blood Glucose (FBG) was checked at day-1 and at the end of 16 weeks. Plasma glycated Haemoglobin (HbA1c), serum insulin, serum Triacylglycerol (TG), Total Cholesterol (TC) and High Density Lipoprotein fraction of Cholesterol (HDL-C) were measured at the end of the study. Statistical analysis was done using the software SPSS-20. Results: Significant decrease in FBG in a dose dependent manner was observed along with increase in serum insulin and decrease in HbA1c levels. Treatment with GSE decreased TG levels significantly and was comparable with Glb. Improvement in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was not significant, but that of Triglyceride Glucose Index (TGI) was significant. GSE at the dose of 2.5g/kg body weight showed a positive correlation between HOMA-IR and TGI (p=0.01) and was comparable with the results of Glb. Conclusion: GSE had a sustained and dose dependent effect in improving glycaemic parameters and TG in diabetic rats of protracted duration. Insulin resistance did not vary significantly from the diabetic control rats.

AB - Introduction: Dysregulation in glucose and lipid metabolism have been observed in the early phases of Diabetes Mellitus (DM) which may further lead to insulin resistance and beta-cell failure. Effective control of these metabolic alterations may delay the clinical onset of diabetes. A proven herbal medication with antihyperglycaemic activity used in the treatment of Diabetes is Gymnema sylvestre (GSE). An extensive study regarding its benefits in treating long standing diabetes and associated dyslipidemia is obligatory. Aim: To study the effects and optimal dosage of a standardized hydroalcoholic leaf extract of GSE on glycaemic and lipid parameters in diabetic rats. Materials and Methods: Wistar rats of either sex were divided into five groups with eight rats in each group. Single dose of Streptozotocin (STZ) (50mg/Kg body weight) was used to induce DM. The diabetic rats were treated with two oral doses of the GSE at 1g and 2.5 g/kg body wt/day and Glibenclamide (Glb) (500 µg/kg body weight) for a period of 16 weeks. Fasting Blood Glucose (FBG) was checked at day-1 and at the end of 16 weeks. Plasma glycated Haemoglobin (HbA1c), serum insulin, serum Triacylglycerol (TG), Total Cholesterol (TC) and High Density Lipoprotein fraction of Cholesterol (HDL-C) were measured at the end of the study. Statistical analysis was done using the software SPSS-20. Results: Significant decrease in FBG in a dose dependent manner was observed along with increase in serum insulin and decrease in HbA1c levels. Treatment with GSE decreased TG levels significantly and was comparable with Glb. Improvement in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was not significant, but that of Triglyceride Glucose Index (TGI) was significant. GSE at the dose of 2.5g/kg body weight showed a positive correlation between HOMA-IR and TGI (p=0.01) and was comparable with the results of Glb. Conclusion: GSE had a sustained and dose dependent effect in improving glycaemic parameters and TG in diabetic rats of protracted duration. Insulin resistance did not vary significantly from the diabetic control rats.

UR - http://www.scopus.com/inward/record.url?scp=85056593413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056593413&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2018/38378.12291

DO - 10.7860/JCDR/2018/38378.12291

M3 - Article

AN - SCOPUS:85056593413

VL - 12

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 11

ER -